Scilex raises Vivasor credit line cap to $30M

Scilex’s current Chief Executive Officer, President and Chairperson also serves as Vivasor’s Chief Executive Officer; the amendment received Board and Audit Committee approval.

Rhea-AI Filing Summary

Scilex Holding Company amended its uncommitted revolving line of credit with Vivasor, Inc., raising the maximum aggregate principal amount from up to $20,000,000 to up to $30,000,000. The amendment was entered into on September 25, 2026, and Vivasor is the borrower; no other changes were made to the note. Dr. Henry Ji, Ph.D., Scilex’s current Chief Executive Officer, President and Chairperson, also serves as Vivasor’s Chief Executive Officer. Scilex’s Board of Directors and Audit Committee approved the amendment.

8-K Event Classification

2 items: 1.01, 9.01

2 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Maximum Credit Amount: $30,000,000 Prior Maximum Credit Amount: $20,000,000 Warrant exercise price: $402.50 per share

3 metrics

Maximum Credit Amount $30,000,000 Amended maximum for the uncommitted revolving line of credit with Vivasor.

Prior Maximum Credit Amount $20,000,000 Maximum before the September 25, 2026 amendment.

Warrant exercise price $402.50 per share Warrants to purchase one share of common stock, trading symbol SCLXW.

Key Terms

uncommitted revolving line of credit, Maximum Credit Amount, aggregate principal amount

3 terms

uncommitted revolving line of credit financial

"an uncommitted revolving line of credit"

Maximum Credit Amount financial

"the “Maximum Credit Amount”"

aggregate principal amount financial

"maximum aggregate principal amount of up to $20,000,000"

The aggregate principal amount is the total amount of money borrowed through a bond or loan that the borrower promises to repay. It’s like the original price tag on a loan or bond, showing how much money is involved in the deal. This number matters because it indicates the size of the debt and helps investors understand the scale of the borrowing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How large is the SCLX-Vivasor credit line after the amendment?

The uncommitted line’s maximum aggregate principal amount is up to $30,000,000, increased from up to $20,000,000.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/29/2026 - 04:07 PM Accepted by SEC EDGAR 09/29/2026 - 04:07 PM Learn about SEC filing dates

false00018201900001820190sclx:WarrantsToPurchaseOneShareOfCommonStockEachAtAnExercisePriceOf40250PerShareMember2026-09-252026-09-2500018201902026-09-252026-09-250001820190sclx:CommonStockParValue00001PerShare2Member2026-09-252026-09-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_______________________

FORM 8-K
_______________________

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 25, 2026

_______________________

SCILEX HOLDING COMPANY
(Exact name of registrant as specified in its charter)
_______________________

Delaware
(State or other jurisdiction
of incorporation) 001-39852
(Commission
File Number) 92-1062542
(IRS Employer
Identification No.)

960 San Antonio Road, Palo Alto, California, 94303
(Address of principal executive offices, including zip code)

(650) 516-4310

Registrant’s telephone number, including area code

N/A
(Former Name or Former Address, if Changed Since Last Report)

_______________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:

(Title of each class)	(Trading Symbol)	(Name of exchange on which registered)
Common Stock, par value $0.0001 per share	SCLX	The Nasdaq Stock Market LLC
Warrants to purchase one share of common stock, each at an exercise price of $402.50	SCLXW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Item 1.01. Entry into a Material Definitive Agreement.

As previously disclosed, on August 8, 2026, Scilex Holding Company (the “Company”) entered into a Promissory Note (Revolving Line of Credit) (the “Note”) with Vivasor, Inc. (“Vivasor”), as borrower, pursuant to which the Company established in favor of Vivasor an uncommitted revolving line of credit in a maximum aggregate principal amount of up to $20,000,000 (the “Maximum Credit Amount”). On September 25, 2026, the Company and Vivasor entered into an amendment to the Note (the “Amendment”), pursuant to which the Maximum Credit Amount was increased from $20,000,000 to $30,000,000. No other changes were made to the Note.

Dr. Henry Ji, Ph.D., the Company’s current Chief Executive Officer, President and Chairperson, currently serves as the Chief Executive Officer of Vivasor. The Amendment was approved by the Company’s Board of Directors (the “Board”) and the Audit Committee of the Board.

A copy of the Amendment is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number	Description
10.1	Amendment to Promissory Note (Revolving Line of Credit), dated September 25, 2026, by and between Vivasor, Inc. and Scilex Holding Company.
104	Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SCILEX HOLDING COMPANY
	By:	/s/ Stephen Ma
	Name:	Stephen Ma
Date: September 29, 2026	Title:	Senior Vice President, Chief Operating Officer and Chief Financial Officer

3

Filing Exhibits & Attachments

2 documents

Agreements & Contracts

• EX-10.1 EX-10.1 50.0 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 56.1 KB